Eversept Partners, LP

CIK 0001697013 · NEW YORK, NY · Quarter end: 2026-06-30 · Filed on: 2026-08-14 · Open the SEC source

Eversept Partners, LP reported 120 positions worth $1.93B as of June 30, 2026 (13F filed August 14, 2026). Largest holding: UTHR (8.1%).

Portfolio Value (AUM)Total value of the fund's US stock portfolio reported to the SEC.
$1.93B
2026 Q2
Positions
120
Top-10 ConcentrationHow much of the portfolio sits in the 10 largest holdings. High = concentrated bets.
45.7%
Est. Net Flow (Q)
2026 Q2
10 / 120 positions shown
#SymbolCompanyTypeValue% Port.Shares1YYTD
1UTHRUNITED THERAPEUTICS CORP DELSH$155.9M8.09%287,668
2ABVXABIVAX SASH$121.8M6.32%913,880
3EHCENCOMPASS HEALTH CORPSH$103.8M5.38%1,026,919
4ENSGENSIGN GROUP INCSH$96.5M5.01%602,079
5VERAVERA THERAPEUTICS INCSH$94.9M4.93%2,212,770
6QQQINVESCO QQQ TRPUT$72.6M3.77%98,600
7CLDXCELLDEX THERAPEUTICS INC NEWSH$66.5M3.45%1,785,941
8SNDXSYNDAX PHARMACEUTICALS INCSH$61.2M3.17%2,798,210
9BKDBROOKDALE SR LIVING INCSH$54.6M2.84%3,396,470
10IONSIONIS PHARMACEUTICALS INCSH$52.7M2.73%664,684

The free plan shows the top 10 positions. The remaining 110 positions, the full portfolio and quarter changes unlock with Pro.

Pro Feature

This section is exclusive to Fundocap Pro. Full holdings tables, consensus trades, ownership analysis, backtests and exports unlock with Pro.

Upgrade to Pro

Read the 2026-Q2 quarterly report · 13F Filing Calendar

Frequently Asked Questions

What stocks does Eversept Partners, LP hold as of Q2 2026?

Eversept Partners, LP reported 120 positions worth $1.93B in its Q2 2026 13F filing. Largest positions: UTHR (8.1%), ABVX (6.3%), EHC (5.4%), ENSG (5.0%) and VERA (4.9%).

What did Eversept Partners, LP buy in Q2 2026?

No previous quarter is available yet; the comparison appears with the next filing.

What did Eversept Partners, LP sell in Q2 2026?

No previous quarter is available yet.

13F data shows quarter-end positions, is delayed by up to 45 days and covers only long positions in US-listed securities; short positions, most derivatives and non-US assets are not reported.